N2OFF, Inc. (NITO) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, N2OFF reported revenue of $0, down 100.0% from $210,000 the year before. Net income was -$4.0M, or -$60.27 per diluted share. Operating activities generated -$3.8M of cash, leaving -$3.8M of free cash flow. At fiscal year end, N2OFF held $20.4M in total assets against $4.7M in total liabilities, including $3.8M of cash and equivalents.
Open the full interactive N2OFF financials → Quarterly statements, key ratios, valuation history and price charts.
N2OFF Key Stats
| Share Price | $0.70 |
|---|---|
| Market Cap | $574,560 |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $0.70 – $31.36 |
| Shares Outstanding | 816,136 (basic, 2026 Q2) |
N2OFF Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $232,274 | $438,141 | $394,004 | $263,445 | $210,000 | $0 |
| Cost of Goods Sold | $43,405 | $135,943 | $158,313 | $55,178 | $165,000 | — |
| Gross Profit | $188,869 | $302,198 | $235,691 | $208,267 | $45,000 | — |
| Operating Income | -$1.3M | -$4.7M | -$5.8M | -$7.6M | -$4.3M | -$4.2M |
| Pre-Tax Income | -$1.6M | -$4.8M | -$5.7M | -$6.5M | -$5.2M | -$3.6M |
| Income Tax | — | — | — | — | — | -$18,000 |
| Net Income | -$1.6M | -$4.8M | -$5.7M | -$6.5M | -$5.2M | -$4.0M |
| Diluted EPS | -$1800.75 | -$3532.90 | — | $1330.35 | -$218.05 | -$60.27 |
N2OFF Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2,000 | — | $0 | $0 |
| Net Income | $429,000 | $1.3M | -$6.6M | -$11.1M |
| Diluted EPS | $6.79 | $0.99 | -$10.74 | -$13.66 |
N2OFF Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $242,900 | $6.8M | $5.7M | $4.4M | $2.2M | $3.8M |
| Current Assets | $495,171 | $7.2M | $6.3M | $5.5M | $3.4M | $6.0M |
| Total Assets | $687,649 | $7.6M | $6.5M | $7.2M | $5.5M | $20.4M |
| Current Liabilities | $785,233 | $931,304 | $714,849 | $778,472 | $892,000 | $1.4M |
| Total Long-Term Debt | $16,064 | $16,780 | — | — | $365,000 | $1.9M |
| Total Liabilities | $1.2M | $1.2M | $754,872 | $785,653 | $892,000 | $4.7M |
| Shareholders' Equity | -$436,176 | $6.5M | $5.8M | $6.5M | $4.7M | $16.0M |
N2OFF Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$798,740 | -$4.1M | -$5.1M | -$3.2M | -$3.4M | -$3.8M |
| Cash From Investing | $9,065 | -$82,790 | -$51,689 | -$1.5M | -$1.9M | -$3.2M |
| Cash From Financing | $741,760 | $10.7M | $4.1M | $3.5M | $3.0M | $8.9M |
| Free Cash Flow | -$822,067 | -$4.2M | -$5.1M | -$3.3M | — | -$3.8M |
Figures from N2OFF's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full N2OFF financials page for every line item.
N2OFF Company Profile
| Ticker | NITO |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | New York, New York |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001789192 |
Frequently Asked Questions
What was N2OFF's revenue in fiscal 2025?
N2OFF (NITO) reported revenue of $0 for fiscal 2025.
What is N2OFF's annual revenue history?
N2OFF's annual revenue by fiscal year: 2020: $232,274; 2021: $438,141; 2022: $394,004; 2023: $263,445; 2024: $210,000; 2025: $0.
What was N2OFF's net income in fiscal 2025?
N2OFF reported net income of -$4.0M for fiscal 2025.
What was N2OFF's earnings per share (EPS) in fiscal 2025?
N2OFF's diluted EPS was -$60.27 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did N2OFF generate in fiscal 2025?
N2OFF generated -$3.8M of free cash flow in fiscal 2025.
What was N2OFF's revenue last quarter?
In its most recent reported quarter (2026 Q2), N2OFF reported revenue of $0.
How much debt does N2OFF have?
N2OFF reported $1.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of N2OFF are outstanding?
N2OFF reported a weighted average of 816,136 basic shares outstanding in 2026 Q2.
What is N2OFF's market cap?
Based on its latest closing price, N2OFF (NITO) has a market capitalization of about $574,560.
When does N2OFF's fiscal year end?
N2OFF's fiscal year end, as registered with the SEC, is December 31.
Where is N2OFF headquartered?
N2OFF lists its business address in New York, New York in its SEC filings.